Newsletter Archive

1. 10.29.25 -- Pharma Direct-To-Patient 2.0: From Experiment To Imperative 10/29/2025
   10/29/25 Life Science Leader Newsletter
2. 10.27.25 -- Developing Cannabinoid And Psychedelic Combination Therapies 10/27/2025
   10/27/25 Life Science Leader Newsletter
3. 10.27.25 -- Innovative Solutions For Complex Clinical Development 10/27/2025
   10/27/25 Life Science Leader Newsletter
4. 10.24.25 -- Reducing Legal Spend Without Compromising Quality 10/24/2025
   10/24/25 Life Science Leader Newsletter
5. 10.23.25 -- Transform Clinical Trials With Real-Time Insights 10/23/2025

   10/23/25 Life Science Leader Newsletter

6. 10.17.25 -- Keep Pace With The Next Wave Of Genetic Therapies 10/17/2025
   10/17/25 Life Science Leader Newsletter
7. 10.15.25 -- The Death Of A Dogma: David Baltimore And Lessons For Modern Drug Discovery 10/15/2025
   10/15/25 Life Science Leader Newsletter
8. 10.13.25 -- AI In Disclosure: Tips, Technology, And More 10/13/2025

   10/13/25 Life Science Leader Newsletter

9. 10.11.25 -- Life Science Leader Best Of September 10/11/2025
   10/11/25 Life Science Leader Newsletter
10. 10.10.25 -- CDMO Hunger Games And The State Of Biotech 10/10/2025
    10/10/25 Life Science Leader Newsletter